{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:21:59Z","timestamp":1789932119752,"version":"4.0.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The list of genes associated with systemic inflammatory diseases has been steadily growing because of the explosion of new genomic technologies. Significant advances in the past year have deepened our understanding of the molecular mechanisms linked to inflammation and elucidated insights on the efficacy of specific therapies for these and related conditions. We review the molecular pathogenesis of four recently characterized monogenic autoinflammatory diseases: haploinsufficiency of A20, otulipenia, a severe form of pyrin-associated disease, and a monogenic form of systemic juvenile idiopathic arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      The scope of autoinflammation has been broadened to include defects in deubiquitination and cellular redox homeostasis. At the clinical level, we discuss the biological rationale for treatment with cytokine inhibitors and colchicine in respective conditions and the use of interleukin\n                      <jats:italic toggle=\"yes\">-<\/jats:italic>\n                      1 antagonism for diagnostic and therapeutic purposes in the management of undifferentiated autoinflammatory disorders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Gene discoveries coupled with studies of molecular function provide knowledge into the biology of inflammatory responses and form the basis for genomically informed therapies. Diseases of dysregulated ubiquitination constitute a novel category of human inflammatory disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000362","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T09:37:53Z","timestamp":1480585073000},"page":"187-194","source":"Crossref","is-referenced-by-count":42,"title":["Lessons from characterization and treatment of the autoinflammatory syndromes"],"prefix":"10.1097","volume":"29","author":[{"given":"Ivona","family":"Aksentijevich","sequence":"first","affiliation":[{"name":"Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"McDermott","sequence":"additional","affiliation":[{"name":"NIHR National Institute for Health Research\u2013Leeds Musculoskeletal Biomedical Research Unit (NIHR-LMBRU) and Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Wellcome Trust Brenner Building, St. James's University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","article-title":"Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling","volume":"33","author":"de Jesus","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"de Jesus","year":"2014","journal-title":"Ann Rev Med"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ni.2892","article-title":"Immune diseases caused by mutations in kinases and components of the ubiquitin system","volume":"15","author":"Cohen","year":"2014","journal-title":"Nat Immunol"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ng.202","article-title":"Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus","volume":"40","author":"Musone","year":"2008","journal-title":"Nat Genet"},{"key":"R7-20230828","first-page":"253","article-title":"Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus","volume":"43","author":"Adrianto","year":"2011","journal-title":"Nat Genet 2011"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"e000223","DOI":"10.1136\/rmdopen-2015-000223","article-title":"Novel heterozygous C243Y A20\/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behcet's diseases","volume":"2","author":"Shigemura","year":"2016","journal-title":"RMD Open"},{"key":"R9-20230828","article-title":"A Japanese family case with juvenile onset Behcet's disease caused by TNFAIP3 mutation","author":"Ohnishi","year":"2016","journal-title":"Allergol Int"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.molcel.2010.10.009","article-title":"Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling","volume":"40","author":"Bosanac","year":"2010","journal-title":"Mol Cell"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Vande Walle","year":"2014","journal-title":"Nature"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2014.12.031","article-title":"A20 restricts ubiquitination of pro-interleukin-1beta protein complexes and suppresses NLRP3 inflammasome activity","volume":"42","author":"Duong","year":"2015","journal-title":"Immunity"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri3313","article-title":"A20: linking a complex regulator of ubiquitylation to immunity and human disease","volume":"12","author":"Ma","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ng.2007.32","article-title":"Rheumatoid arthritis association at 6q23","volume":"39","author":"Thomson","year":"2007","journal-title":"Nat Genet"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","article-title":"Failure to regulate TNF-induced NF-\u03baB and cell death responses in A20-deficient mice","volume":"289","author":"Lee","year":"2000","journal-title":"Science"},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ng.916","article-title":"A20 edits ubiquitin and autoimmune paradigms","volume":"43","author":"Martin","year":"2011","journal-title":"Nat Genet"},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molcel.2013.06.004","article-title":"OTULIN restricts Met1-linked ubiquitination to control innate immune signaling","volume":"50","author":"Fiil","year":"2013","journal-title":"Mol Cell"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2013.05.014","article-title":"OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin","volume":"153","author":"Keusekotten","year":"2013","journal-title":"Cell"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrm3836","article-title":"Linear ubiquitin chains: NF-kappaB signalling, cell death and beyond","volume":"15","author":"Iwai","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1111\/febs.12944","article-title":"Met1-linked ubiquitination in immune signalling","volume":"281","author":"Fiil","year":"2014","journal-title":"FEBS J"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.molcel.2014.03.016","article-title":"Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB signaling","volume":"54","author":"Schaeffer","year":"2014","journal-title":"Mol Cell"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.2457","article-title":"Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency","volume":"13","author":"Boisson","year":"2012","journal-title":"Nat Immunol"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20141130","article-title":"Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia","volume":"212","author":"Boisson","year":"2015","journal-title":"J Exp Med"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1073\/pnas.1612594113","article-title":"Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease","volume":"113","author":"Zhou","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2016.07.019","article-title":"The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity","volume":"166","author":"Damgaard","year":"2016","journal-title":"Cell"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature12296","article-title":"The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis","volume":"498","author":"Rivkin","year":"2013","journal-title":"Nature"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/BOR.0000000000000315","article-title":"Familial Mediterranean fever","volume":"28","author":"Padeh","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/qjmed\/93.4.217","article-title":"The genetic basis of autosomal dominant familial Mediterranean fever","volume":"93","author":"Booth","year":"2000","journal-title":"QJM"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajmg.a.20296","article-title":"A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder?","volume":"124A","author":"Aldea","year":"2004","journal-title":"Am J Med Genet A"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/annrheumdis-2012-202580","article-title":"MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease","volume":"73","author":"Stoffels","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R34-20230828","article-title":"Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue \u2013 a case series and genetic exploration","author":"Rowczenio","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.24569","article-title":"Familial Mediterranean fever with a single MEFV mutation: where is the second hit?","volume":"60","author":"Booty","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1\u03b2 activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/scitranslmed.aaf1471","article-title":"Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation","volume":"8","author":"Masters","year":"2016","journal-title":"Sci Transl Med"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.chom.2016.07.018","article-title":"The Yersinia virulence factor YopM Hijacks Host kinases to inhibit type III effector-triggered activation of the pyrin inflammasome","volume":"20","author":"Chung","year":"2016","journal-title":"Cell Host Microbe"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"E4857","DOI":"10.1073\/pnas.1601700113","article-title":"Site-specific phosphorylation and microtubule dynamics control pyrin inflammasome activation","volume":"113","author":"Gao","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"HLA-DRB1\u221711 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"15785","DOI":"10.1073\/pnas.1521837113","article-title":"Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis","volume":"112","author":"Nigrovic","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-20230828","article-title":"The burgeoning field of innate immune-mediated disease and autoinflammation","author":"Peckham","year":"2016","journal-title":"J Pathol"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"e55295","DOI":"10.1371\/journal.pone.0055295","article-title":"Structural and phylogenetic analysis of laccases from trichoderma: a bioinformatic approach","volume":"8","author":"C\u00e1zares-Garc\u00eda","year":"2013","journal-title":"PLoS One"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3532","article-title":"C13orf31 (FAMIN) is a central regulator of immunometabolic function","volume":"17","author":"Cader","year":"2016","journal-title":"Nat Immunol"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"e86336","DOI":"10.1172\/jci.insight.86336","article-title":"Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology","volume":"1","author":"Harrison","year":"2016","journal-title":"JCI Insight"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201703000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T01:14:55Z","timestamp":1693185295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201703000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000362","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}